1-3 of 3
Gergely Varga, MD
Close
Sort by
Journal Articles

Efficacy and Safety of Venetoclax Combinations in t(11;14) Multiple Myeloma: Real World Data Collected from 7 Hungarian Centers

Virág Réka Szita, MD, Gábor Mikala, MD PhD, János Fábián, MD, Péter Rajnics, MD PhD, László Rejtő, MD PhD, Tamás Szendrei, MD, Hussain Alizadeh, MD PhD DSc, Laszlo Varoczy, MD PhD, Árpád Illés, MD PhD, Tamas Masszi, MD PhD, Gergely Varga, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-139870
Published: 2020
Journal Articles

Real World Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

Gergely Varga, MD PhD, Zsolt Nagy, MD PhD, Szabolcs Kosztolányi, MD, Árpád Szomor, MD PhD, Tamás Schneider, MD PhD, Beáta Deák, MD PhD, Krisztina Wolf, MD, Márk Plander, MD PhD, Tamás Szendrei, MD, László Váróczy, MD PhD, Árpád Illés, MD PhD, Árpád Bátai, MD, Mónika Pető, MD, János Fábián, MD, Tamas Masszi, MD PhD, Gabor Mikala, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1865.
https://doi.org/10.1182/blood.V130.Suppl_1.1865.1865
Published: 2017
Journal Articles

The Effect of Proteasome Subunit Beta Type 1 P11A Polymorphism on the Survival of Multiple Myeloma Patients Treated with First Line Bortezomib Based Chemotherapy

Gergely Varga, MD, Gabor Mikala, MD PhD, Gergely Szombath, MD, Katalin Balassa, MD, Katalin Piroska Kiss, MD, Attila Tordai, PhD DSc, Hajnalka Andrikovics, MD PhD, Tamas Masszi, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1765.
https://doi.org/10.1182/blood.V126.23.1765.1765
Published: 2015